TY - JOUR
T1 - Impact of age on the management and prognosis of esophageal fistula after atrial fibrillation ablation—a subanalysis of the worldwide POTTER-AF study
AU - the POTTER-AF investigators
AU - Popescu, Sorin S.
AU - Demirtakan, Zeynep G.
AU - Schmidt, Vanessa
AU - Pürerfellner, Helmut
AU - Sommer, Philipp
AU - Sohns, Christian
AU - Veltmann, Christian
AU - Steven, Daniel
AU - Chun, K. R.Julian
AU - Maury, Philippe
AU - Gandjbakhch, Estelle
AU - Laredo, Mikael
AU - Willems, Stephan
AU - Beiert, Thomas
AU - Iden, Leon
AU - Füting, Anna
AU - Spittler, Raphael
AU - Richter, Sergio
AU - Schade, Anja
AU - Kuniss, Malte
AU - Wunderlich, Carsten
AU - Shin, Dong In
AU - Grosse Meininghaus, Dirk
AU - Bonsels, Marc
AU - Reek, David
AU - Wiegand, Uwe
AU - Bauer, Alexander
AU - Metzner, Andreas
AU - Eckardt, Lars
AU - Krahnefeld, Olaf
AU - Sticherling, Christian
AU - Kühne, Michael
AU - Nguyen, Dinh Quang
AU - Roten, Laurent
AU - Linz, Dominik
AU - van der Voort, Pepijn
AU - Mulder, Bart A.
AU - Vijgen, Johan
AU - Almorad, Alexandre
AU - Guenancia, Charles
AU - Fauchier, Laurent
AU - Boveda, Serge
AU - De Greef, Yves
AU - Da Costa, Antoine
AU - Jais, Pierre
AU - Milhem, Antoine
AU - Jesel, Laurence
AU - Garcia, Rodrigue
AU - Poty, Hervé
AU - Reddy, Vivek
N1 - Publisher Copyright:
2026 Popescu, Demirtakan, Schmidt, Pürerfellner, Sommer, Sohns, Veltmann, Steven, Chun, Maury, Gandjbakhch, Laredo, Willems, Beiert, Iden, Füting, Spittler, Richter, Schade, Kuniss, Wunderlich, Shin, Grosse Meininghaus, Bonsels, Reek, Wiegand, Bauer, Metzner, Eckardt, Krahnefeld, Sticherling, Kühne, Nguyen, Roten, Linz, van der Voort, Mulder, Vijgen, Almorad, Guenancia, Fauchier, Boveda, De Greef, Da Costa, Jais, Milhem, Jesel, Garcia, Poty, Khoueiry, Seitz, Laborderie, Mechulan, Brigadeau, Zhao, Saludas, Piot, Ahluwalia, Martin, Chen, Antolic, Leventopoulos, Özcan, Yorgun, Cay, Yalin, Sobhy Botros, Jędrzejczyk-Patej, Inaba, Okumura, Ejima, Khakpour, Catanzaro, Reddy, Natale, Blessberger, Yang, Vogler, Kuck, Merino, Keelani, Heeger and Tilz.
PY - 2026
Y1 - 2026
N2 - Background: Esophageal fistula (EF) is a rare but devastating complication following atrial fibrillation (AF) ablation. Data regarding the impact of age on EF are scarce. Objective: To study the impact of age on the management and prognosis of EF following catheter ablation for AF. Methods: The POTTER-AF study is a worldwide registry on EF following catheter ablation for AF. A total of 553,729 patients underwent AF ablation in 214 centers between 1996 and 2022. Of them, 138 patients experienced EF, and data regarding age, management, and prognosis were available in 113 patients. The population was divided based on the median age. Results: The median age was 63 years; 54 patients were <63 years old (Group 1), and 59 patients were ≥63 years old (Group 2). The groups were similar regarding procedural characteristics. The older population had a shorter time to symptom onset [15.0 (6.0, 21.0) vs. 21.0 (10.0, 25.3) days; p = 0.031]. Group 2 was less likely to receive a brain CT or MRI for diagnosis (25.9% vs. 45.3%; p = 0.046). The older population was more likely to undergo endoscopic treatment without surgery (27.6% vs. 11.3%; p = 0.035). Conservative and surgical treatments were used in similar proportions. A trend toward higher fatality was noted in the older patients (72.9% vs. 56.6%; p = 0.078). Conclusion: The older population had a shorter time to symptom onset, was less likely to receive a brain CT or MRI, and more likely to be treated by an endoscopic approach only. The older patient group showed a trend toward a higher fatality.
AB - Background: Esophageal fistula (EF) is a rare but devastating complication following atrial fibrillation (AF) ablation. Data regarding the impact of age on EF are scarce. Objective: To study the impact of age on the management and prognosis of EF following catheter ablation for AF. Methods: The POTTER-AF study is a worldwide registry on EF following catheter ablation for AF. A total of 553,729 patients underwent AF ablation in 214 centers between 1996 and 2022. Of them, 138 patients experienced EF, and data regarding age, management, and prognosis were available in 113 patients. The population was divided based on the median age. Results: The median age was 63 years; 54 patients were <63 years old (Group 1), and 59 patients were ≥63 years old (Group 2). The groups were similar regarding procedural characteristics. The older population had a shorter time to symptom onset [15.0 (6.0, 21.0) vs. 21.0 (10.0, 25.3) days; p = 0.031]. Group 2 was less likely to receive a brain CT or MRI for diagnosis (25.9% vs. 45.3%; p = 0.046). The older population was more likely to undergo endoscopic treatment without surgery (27.6% vs. 11.3%; p = 0.035). Conservative and surgical treatments were used in similar proportions. A trend toward higher fatality was noted in the older patients (72.9% vs. 56.6%; p = 0.078). Conclusion: The older population had a shorter time to symptom onset, was less likely to receive a brain CT or MRI, and more likely to be treated by an endoscopic approach only. The older patient group showed a trend toward a higher fatality.
KW - age
KW - atrial fibrillation
KW - catheter ablation
KW - complication
KW - esophageal fistula
UR - https://www.scopus.com/pages/publications/105032445340
U2 - 10.3389/fcvm.2025.1708499
DO - 10.3389/fcvm.2025.1708499
M3 - Article
AN - SCOPUS:105032445340
SN - 2297-055X
VL - 12
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
M1 - 1708499
ER -